Ieq Capital LLC Purchases Shares of 47,425 Alignment Healthcare, Inc. $ALHC

Ieq Capital LLC purchased a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) in the second quarter, according to its most recent filing with the SEC. The firm purchased 47,425 shares of the company’s stock, valued at approximately $1,129,000.

Several other hedge funds have also recently made changes to their positions in the business. Bank of America Corp DE increased its stake in shares of Alignment Healthcare by 156.5% in the 1st quarter. Bank of America Corp DE now owns 3,215,667 shares of the company’s stock valued at $56,660,000 after acquiring an additional 1,961,778 shares in the last quarter. 1492 Capital Management LLC boosted its stake in Alignment Healthcare by 61.8% during the fourth quarter. 1492 Capital Management LLC now owns 324,865 shares of the company’s stock worth $6,416,000 after acquiring an additional 124,143 shares in the last quarter. Danica Pension Livsforsikringsaktieselskab bought a new position in Alignment Healthcare during the fourth quarter worth $39,500,000. William Blair Investment Management LLC grew its holdings in Alignment Healthcare by 8.7% in the fourth quarter. William Blair Investment Management LLC now owns 2,305,255 shares of the company’s stock worth $45,529,000 after purchasing an additional 185,303 shares during the period. Finally, Simplify Asset Management Inc. grew its holdings in Alignment Healthcare by 92.0% in the fourth quarter. Simplify Asset Management Inc. now owns 262,880 shares of the company’s stock worth $5,192,000 after purchasing an additional 125,946 shares during the period. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC opened at $13.90 on Thursday. The stock has a market cap of $2.88 billion, a price-to-earnings ratio of 73.16 and a beta of 1.10. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.70 and a current ratio of 1.70. Alignment Healthcare, Inc. has a fifty-two week low of $12.70 and a fifty-two week high of $25.12. The firm’s 50-day simple moving average is $18.42 and its 200 day simple moving average is $18.63.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. The firm had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.31 billion. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The company’s revenue for the quarter was up 31.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.07 EPS. As a group, research analysts anticipate that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current fiscal year.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

• Neutral Sentiment: An AAII report discussed why Alignment Healthcare stock had risen, but the available headline provides no specific new fundamental catalyst, such as improved earnings guidance or a business announcement. Why Alignment Healthcare Stock Is Up
• Neutral Sentiment: Reported August short-interest data showed zero shares and a zero-day days-to-cover ratio, an internally inconsistent result that is unlikely to provide a meaningful signal for ALHC investors. Alignment Healthcare Short Interest Report
• Negative Sentiment: Kaplan Fox announced multiple investigations into Alignment Healthcare, its officers and directors, and potential violations of federal securities laws. The firm is seeking investors who suffered losses or have relevant information, raising the possibility of future shareholder claims. These are investigations and do not establish wrongdoing. Kaplan Fox Investigation
• Negative Sentiment: Lowey Dannenberg separately said it is investigating potential federal securities-law violations involving ALHC. The second law-firm inquiry reinforces near-term litigation uncertainty and could weigh on investor sentiment. Lowey Dannenberg Investigation
• Negative Sentiment: Kaplan Fox also urged Alignment Healthcare investors to contact the firm regarding a possible securities claim, repeating the investigation-related overhang across several releases. Kaplan Fox Possible Securities Claim

Insider Activity at Alignment Healthcare

In related news, EVP Joseph S. Konowiecki sold 25,000 shares of the company’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total transaction of $600,000.00. Following the completion of the sale, the executive vice president owned 1,103,816 shares in the company, valued at approximately $26,491,584. This represents a 2.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Hyong Kim sold 35,951 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $19.86, for a total value of $713,986.86. Following the completion of the sale, the insider directly owned 331,750 shares of the company’s stock, valued at $6,588,555. The trade was a 9.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,009,951 shares of company stock valued at $18,597,287 over the last 90 days. Corporate insiders own 5.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ALHC. Weiss Ratings reiterated a “hold (c-)” rating on shares of Alignment Healthcare in a report on Tuesday, August 4th. Wall Street Zen downgraded Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. UBS Group reaffirmed a “neutral” rating on shares of Alignment Healthcare in a research report on Wednesday, July 8th. Raymond James Financial lowered Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and cut their price target for the stock from $22.00 to $19.00 in a report on Monday, August 3rd. Finally, Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Seven equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $23.60.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.